Martha Holtje
Examiner (ID: 17181)
Most Active Art Unit | 2913 |
Art Unit(s) | 2903, 2900, 2912, 2913 |
Total Applications | 5459 |
Issued Applications | 5384 |
Pending Applications | 1 |
Abandoned Applications | 74 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 18254842
[patent_doc_number] => 20230081881
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-16
[patent_title] => TRANSPOSON-BASED MODULATION OF GBA1 AND RELATED COMPOSITIONS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/813915
[patent_app_country] => US
[patent_app_date] => 2022-07-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 58663
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -38
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17813915
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/813915 | TRANSPOSON-BASED MODULATION OF GBA1 AND RELATED COMPOSITIONS AND USES THEREOF | Jul 19, 2022 | Pending |
Array
(
[id] => 17748174
[patent_doc_number] => 20220226377
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-21
[patent_title] => TREATMENT OF DIABETES USING IMMUNE CELLS REPROGRAMMED EX VIVO BY REGENERATIVE CELLS
[patent_app_type] => utility
[patent_app_number] => 17/578298
[patent_app_country] => US
[patent_app_date] => 2022-01-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8726
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 82
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17578298
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/578298 | TREATMENT OF DIABETES USING IMMUNE CELLS REPROGRAMMED EX VIVO BY REGENERATIVE CELLS | Jan 17, 2022 | Abandoned |
Array
(
[id] => 17482511
[patent_doc_number] => 20220090015
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-24
[patent_title] => ENGINEERED IMMUNE CELLS WITH MULTIPLEX AND LOCALIZED ACTIVITY
[patent_app_type] => utility
[patent_app_number] => 17/480476
[patent_app_country] => US
[patent_app_date] => 2021-09-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 36320
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 94
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17480476
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/480476 | ENGINEERED IMMUNE CELLS WITH MULTIPLEX AND LOCALIZED ACTIVITY | Sep 20, 2021 | Pending |
Array
(
[id] => 17482509
[patent_doc_number] => 20220090013
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-24
[patent_title] => ENGINEERING IMMUNE CELLS BASED ON ANTIGEN LEVELS
[patent_app_type] => utility
[patent_app_number] => 17/480462
[patent_app_country] => US
[patent_app_date] => 2021-09-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 36321
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17480462
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/480462 | ENGINEERING IMMUNE CELLS BASED ON ANTIGEN LEVELS | Sep 20, 2021 | Pending |
Array
(
[id] => 17482513
[patent_doc_number] => 20220090017
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-24
[patent_title] => CONTROLLING PROXIMITY OF IMMUNE CELL RECEPTORS
[patent_app_type] => utility
[patent_app_number] => 17/480501
[patent_app_country] => US
[patent_app_date] => 2021-09-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 36321
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17480501
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/480501 | CONTROLLING PROXIMITY OF IMMUNE CELL RECEPTORS | Sep 20, 2021 | Pending |
Array
(
[id] => 18210053
[patent_doc_number] => 20230056314
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-23
[patent_title] => CYTOPROTECTIVE COMPOSITIONS FOR SHORT-TERM CELLS STORAGE AND TRANSPORTATION WITHOUT CRYOPRESERVATION AND DEEP FREEZING
[patent_app_type] => utility
[patent_app_number] => 17/405735
[patent_app_country] => US
[patent_app_date] => 2021-08-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11395
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17405735
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/405735 | CYTOPROTECTIVE COMPOSITIONS FOR SHORT-TERM CELLS STORAGE AND TRANSPORTATION WITHOUT CRYOPRESERVATION AND DEEP FREEZING | Aug 17, 2021 | Pending |
Array
(
[id] => 17426838
[patent_doc_number] => 20220054546
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-24
[patent_title] => CHIMERIC ANTIGEN RECEPTOR T CELLS AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/395184
[patent_app_country] => US
[patent_app_date] => 2021-08-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23274
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17395184
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/395184 | CHIMERIC ANTIGEN RECEPTOR T CELLS AND METHODS OF USE THEREOF | Aug 4, 2021 | Pending |
Array
(
[id] => 17503440
[patent_doc_number] => 20220096542
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-31
[patent_title] => AUGMENTATION OF NATURAL KILLER CELL ACTIVITY AND INDUCTION OF CYTOTOXIC IMMUNITY USING LEUKOCYTE LYSATE ACTIVATED ALLOGENEIC DENDRITIC CELLS: STEMVACS
[patent_app_type] => utility
[patent_app_number] => 17/364646
[patent_app_country] => US
[patent_app_date] => 2021-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2851
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17364646
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/364646 | AUGMENTATION OF NATURAL KILLER CELL ACTIVITY AND INDUCTION OF CYTOTOXIC IMMUNITY USING LEUKOCYTE LYSATE ACTIVATED ALLOGENEIC DENDRITIC CELLS: STEMVACS | Jun 29, 2021 | Pending |
Array
(
[id] => 17098141
[patent_doc_number] => 20210285932
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-16
[patent_title] => CHEMOPREDICTIVE ASSAY FOR RECURRENT CHEMOTHERAPY
[patent_app_type] => utility
[patent_app_number] => 17/218013
[patent_app_country] => US
[patent_app_date] => 2021-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5542
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17218013
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/218013 | CHEMOPREDICTIVE ASSAY FOR RECURRENT CHEMOTHERAPY | Mar 29, 2021 | Abandoned |
Array
(
[id] => 17096908
[patent_doc_number] => 20210284699
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-16
[patent_title] => ADENO-ASSOCIATED VIRAL CAPSIDS WITH EXPANDED SIZES
[patent_app_type] => utility
[patent_app_number] => 17/199293
[patent_app_country] => US
[patent_app_date] => 2021-03-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 53923
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17199293
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/199293 | ADENO-ASSOCIATED VIRAL CAPSIDS WITH EXPANDED SIZES | Mar 10, 2021 | Pending |
Array
(
[id] => 17065808
[patent_doc_number] => 20210268023
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-02
[patent_title] => Enhanced CAR Tregs and Bi-Specific Antibodies for Induction of Immune Tolerance, Treating Autoimmune Diseases and Preventing Transplantation Rejection
[patent_app_type] => utility
[patent_app_number] => 17/188640
[patent_app_country] => US
[patent_app_date] => 2021-03-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13902
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17188640
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/188640 | Enhanced CAR Tregs and Bi-Specific Antibodies for Induction of Immune Tolerance, Treating Autoimmune Diseases and Preventing Transplantation Rejection | Feb 28, 2021 | Pending |
Array
(
[id] => 16914010
[patent_doc_number] => 20210187102
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-24
[patent_title] => METHOD OF OBTAINING A POLYEPITOPIC PROTEIN AND POLYEPITOPIC DNA VECTOR
[patent_app_type] => utility
[patent_app_number] => 17/132103
[patent_app_country] => US
[patent_app_date] => 2020-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4995
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17132103
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/132103 | METHOD OF OBTAINING A POLYEPITOPIC PROTEIN AND POLYEPITOPIC DNA VECTOR | Dec 22, 2020 | Pending |
Array
(
[id] => 16839783
[patent_doc_number] => 20210147795
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-20
[patent_title] => LAYERED BODY
[patent_app_type] => utility
[patent_app_number] => 17/094935
[patent_app_country] => US
[patent_app_date] => 2020-11-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16956
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17094935
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/094935 | LAYERED BODY | Nov 10, 2020 | Pending |
Array
(
[id] => 16511679
[patent_doc_number] => 20200390936
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-17
[patent_title] => METHOD FOR CRYOPRESERVING CELLS
[patent_app_type] => utility
[patent_app_number] => 17/004642
[patent_app_country] => US
[patent_app_date] => 2020-08-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11484
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17004642
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/004642 | METHOD FOR CRYOPRESERVING CELLS | Aug 26, 2020 | Abandoned |
Array
(
[id] => 16466746
[patent_doc_number] => 20200368283
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-11-26
[patent_title] => NON-HLA RESTRICTED T CELL RECEPTORS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/990185
[patent_app_country] => US
[patent_app_date] => 2020-08-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28367
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -50
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16990185
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/990185 | NON-HLA RESTRICTED T CELL RECEPTORS AND USES THEREOF | Aug 10, 2020 | Pending |
Array
(
[id] => 16399122
[patent_doc_number] => 20200339980
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-29
[patent_title] => High Specificity Genome Editing Using Chemically Modified Guide RNAs
[patent_app_type] => utility
[patent_app_number] => 16/929948
[patent_app_country] => US
[patent_app_date] => 2020-07-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 53084
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16929948
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/929948 | High Specificity Genome Editing Using Chemically Modified Guide RNAs | Jul 14, 2020 | Pending |
Array
(
[id] => 16673110
[patent_doc_number] => 20210061873
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-04
[patent_title] => COMPOSITIONS AND METHODS FOR NEUROLOGICAL DISEASES
[patent_app_type] => utility
[patent_app_number] => 16/925174
[patent_app_country] => US
[patent_app_date] => 2020-07-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 37807
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -29
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16925174
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/925174 | COMPOSITIONS AND METHODS FOR NEUROLOGICAL DISEASES | Jul 8, 2020 | Pending |
Array
(
[id] => 17383895
[patent_doc_number] => 20220031747
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-03
[patent_title] => FOXP1-ABLATED CHIMERIC CELLS
[patent_app_type] => utility
[patent_app_number] => 17/297897
[patent_app_country] => US
[patent_app_date] => 2020-01-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13299
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17297897
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/297897 | FOXP1-ABLATED CHIMERIC CELLS | Jan 5, 2020 | Pending |
Array
(
[id] => 16091103
[patent_doc_number] => 20200199538
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-25
[patent_title] => DERIVATION OF LIVER ORGANOIDS FROM HUMAN PLURIPOTENT STEM CELLS
[patent_app_type] => utility
[patent_app_number] => 16/732948
[patent_app_country] => US
[patent_app_date] => 2020-01-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 36956
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16732948
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/732948 | DERIVATION OF LIVER ORGANOIDS FROM HUMAN PLURIPOTENT STEM CELLS | Jan 1, 2020 | Pending |
Array
(
[id] => 17444092
[patent_doc_number] => 20220064597
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-03
[patent_title] => Generation of organoid-primed T (opT) cells with memory phenotype
[patent_app_type] => utility
[patent_app_number] => 17/414907
[patent_app_country] => US
[patent_app_date] => 2019-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6517
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 77
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17414907
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/414907 | Generation of organoid-primed T (opT) cells with memory phenotype | Dec 17, 2019 | Pending |